Untitled Document
PRODUCTSORDERINGTECHNICAL RESOURCESABOUT USKEY CONTACTS HOME
Employment OpportunitiesNEWS/PR
December News


Expedeon and Protein Technologies Join Forces to Provide

Custom Protein Services

CAMBRIDGE, UNITED KINGDOM and MANCHESTER, UNITED KINGDOM (Dec 15, 2011) - Expedeon, Ltd. and Protein Technologies Ltd. today announced a collaborative agreement to provide NVoy based Custom Protein Stabilisation Services.

Expedeon is a leading provider of simple, rapid, and effective solutions for protein-based research and production. The company's patented products include industry-leading solutions for protein separation, quantitation, visualization, purification, protection and refolding.  The company’s proprietary NVoy technology is used worldwide to enhance protein stability and solubility. Applications include soluble expression of aggregation prone protein such as membrane proteins, protein refolding, protein concentration and purification, crystallisation, NMR and mass spectrometry. Expedeon has offices in Cambridge, UK and San Diego, CA. Its products and services are sold direct and through an extensive partner network around the world.

Protein Technologies Ltd (PTL) is a provider of contract research services to the life sciences industries specializing in recombinant protein expression, protein engineering and purification, assay development and drug screening and the development of novel fluorescent proteins. PTL also has proprietary technology in enzyme immobilization and very large scale enzymatic reactions in continuous flow reactors. PTL operates from state-of-the-art development laboratories on the Manchester Science Park.

“Aggregation and solubility is an omnipresent issue when working with proteins. This new service will allow researchers access to state-of-the-art technology with experienced scientists delivering results to customers quickly and efficiently," said Dr Heikki Lanckriet, CEO of Expedeon. “This is a strategic collaboration in our mission to provide enhanced value and capabilities to protein researchers.”

Dr Farid Khan, CSO of Protein Technologies added, "I am thrilled to work with Expedeon and its innovative technologies. We have experienced the benefits of this disruptive technology in our own hands and are excited to be able offer these services to our colleague protein researchers."

About Expedeon

Expedeon Ltd is a privately-held tools and reagents company developing and delivering innovative products for protein discovery and analysis. The company provides researchers globally with unique and reliable products enabling advancements in protein research and drug development. For more information please visit www.expedeon.com.

 

About Protein Technologies

Protein Technologies Ltd (PTL) is a privately owned company offering professional, cost-effective contract research services to the highest standards of customer satisfaction. For the full range of services offered by the company see http://www.protein-technologies.com.